Procter & Gamble Stock Gains After Sales Exceed Expectations

Financial Performance - Procter & Gamble's fiscal 2025 second-quarter net sales grew 2% year-over-year to $21.88 billion, surpassing Wall Street estimates of$21.59 billion [1] - Net income for the quarter was $4.63 billion, or$1.88 per share, matching expectations [1] - The company's shares rose 3% following the earnings report [1][3] Segment Performance - Baby, Feminine & Family Care segment, including Tampax and Pampers, saw a 3% increase in sales [2][3] - Fabric & Home Care segment, featuring Tide and Febreze, and Health Care segment, including Crest and Pepto Bismol, both experienced 2% sales growth [2] - Grooming segment, with Gillette and Venus razors, reported a 1% revenue increase [2] - Beauty segment, including Head & Shoulders and Old Spice, showed flat sales [2] Outlook and Share Repurchase - Procter & Gamble reaffirmed its fiscal 2025 outlook, projecting sales growth of 2% to 4% from $84 billion in the previous year [3] - The company expects earnings per share (EPS) growth of 10$6.02 in fiscal 2024 [3] - Procter & Gamble plans to repurchase $6 to$7 billion worth of shares in the current fiscal year [3]